Status:
TERMINATED
Regulating Homeostatic Plasticity and the Physiological Response to rTMS
Lead Sponsor:
University of Arkansas
Conditions:
Tinnitus
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This device-study includes a pilot, physiological investigation of normal human subjects. The aim is to determine how existing non-invasive neuromodulation devices affect brain circuitry as measured b...
Detailed Description
Background and Rationale: The current proposal aims to combine two forms of neuromodulation, transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), to ...
Eligibility Criteria
Inclusion
- complete the informed consent process
- men and women, age: 21-65 years
- negative pregnancy test (female subjects of childbearing age must take a pregnancy test).
Exclusion
- a personal or family history of epilepsy,
- severe head injury, aneurysm, stroke, previous cranial neurosurgery,
- sever or recurrent migraine headaches,
- metal implants in the head or neck, a pacemaker,
- pregnancy,
- medications that lower seizure threshold,
Key Trial Info
Start Date :
November 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03309696
Start Date
November 16 2017
End Date
October 1 2019
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205